Deals
Rexahn Pharmaceuticals Raises $5M at 14% Discount via Rodman & Renshaw
|
Rexahn Pharmaceuticals (AMEX:RNN) announced that it has raised $5,000,000 in a Registered Direct transaction.
Growth Capitalist (https://growthcapitalist.com/category/deals/page/43/)
Recent growth capital transactions by pre-IPO private and public emerging growth companies
Rexahn Pharmaceuticals (AMEX:RNN) announced that it has raised $5,000,000 in a Registered Direct transaction.
Amicus Therapeutics (NASDAQ GM:FOLD) announced that it has secured up to $100,000,000 in an ATM (At the Market) transaction. The
NovaBay Pharmaceuticals (AMEX:NBY) announced that it has raised $1,260,828 in a Common Stock transaction.
Amarantus BioScience Holdings (OTC:AMBS) announced that it has raised $3,000,000 in a Convertible Preferred Stock transaction.